Advanced machinery for the modern medical manufacturing facility
The global infusion set market is undergoing a paradigm shift, transitioning from simple gravity-fed disposables to highly engineered, precision instruments integrated with smart healthcare systems. Valued at over USD 1.5 billion and projected to grow at a CAGR of 6.2%, the industry is driven by an aging global population and the rising prevalence of chronic diseases requiring long-term intravenous therapies.
In the current industrial climate, OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) partnerships are the bedrock of the medical device supply chain. Pharmaceutical giants and healthcare distributors no longer seek mere suppliers; they seek integrated manufacturing partners who can offer end-to-end solutions from material science innovation to automated cleanroom assembly.
China's medical manufacturing hubs, particularly in regions like Suzhou, offer an unparalleled density of upstream and downstream suppliers. From medical-grade PVC/TPE granules to high-precision injection molds, every component is accessible within a 100km radius, drastically reducing lead times and logistical costs.
Modern Chinese factories have transitioned from labor-intensive assembly to AI-driven robotic lines. Our Flow Regulator Assembling Machines and High-Speed Packing Lines ensure consistency that manual labor cannot match, resulting in a defect rate of less than 0.01%.
Strict adherence to ISO 13485 and CE standards is the baseline. Chinese manufacturers now lead in "Information Gain" by providing comprehensive documentation, biocompatibility reports, and transparent factory audits that meet the most stringent EU and North American regulations.
Standardized infusion sets for rapid deployment in emergency rooms and intensive care units. These require high-pressure resistance and universal compatibility with varied IV pump systems.
Designing infusion sets with "User Intent Mining" in mind—making them easier for non-professionals to handle, featuring intuitive flow regulators and safety-engineered needleless connectors.
Lightweight, durable packaging with extended shelf-life (EO sterilization) optimized for transport into harsh environments where electricity and high-tech infrastructure are unavailable.
Precision-engineered PVC-free and DEHP-free infusion sets designed to handle aggressive pharmacological agents without material leaching or drug absorption.
Suzhou Hanora Medical Supplies Co., Ltd. is founded in 2013. We are a sourcing company focusing on medical devices and lab equipment. We are committed to provide our clients with one-stop sourcing services, serving as their virtual office in China.
Our sourcing services include: product sourcing, price negotiation, supplier verification, factory auditing, production monitoring, lab testing, order follow-up, quality control, pre-shipment inspection, logistics support, etc. We have exported our products to more than 30 countries with a lot experience on sourcing and exporting.
For our clients we promise: the prices we offer are 100% authentic factory-gate prices, and clients are always allowed to pay directly to the factories. Beside business, we also care about the poor people, and we always give 5% from our profit to the charity to make a better world!
For new clients, we provide free services of product sourcing for 3 different products within 1-2 working days.
Transparent payment options directly to factories, ensuring financial security and trust.
All-rounded verification including factory qualifications and customs history records.
Full support for OEM, ODM, sampling, and mixed model shipments.
Moving forward, the industry is witnessing the integration of IoT and Smart Monitoring. Future infusion sets will likely include integrated sensors that relay real-time flow data to centralized nursing stations, reducing human error. Additionally, "Green Manufacturing" is becoming a requirement, with manufacturers pivoting toward bio-based polymers and recyclable medical-grade materials to meet ESG (Environmental, Social, and Governance) goals of global healthcare providers.
The three most critical points are: 1) Material biocompatibility (ensuring no cytotoxic effects), 2) Hermetic sealing of the drip chamber and tubing joints, and 3) Flow regulator precision (ensuring accurate drop counts per ml).
Manufacturing occurs in Class 100,000 cleanrooms. Post-production, sets undergo Ethylene Oxide (EO) or Gamma radiation sterilization, followed by residual testing and bacterial endotoxin testing (BET).
Yes. Through our ODM services, we can specify light-resistant tubing for photosensitive drugs or PE-lined tubing for drugs that interact with PVC.
Standard lead times for existing designs are 25-35 days. For new ODM molds, the process typically takes 60-90 days from design finalization to first production batch.
Hanora Medical
